Liver Cancer a Big Threat to U.S., Other Developed Nations

FRIDAY, June 15, 2018 (HealthDay News) — Liver cancer cases in several developed countries have doubled in the past 25 years, due to the continuing obesity epidemic and a spike in hepatitis infections, new research suggests. Even worse, the sharp rise in liver cancer cases is starting to swamp the limited number of liver specialists in those nations, the researchers added. In the four countries — the United States, the United Kingdom, Australia and Canada — liver cancer is the only major cancer for which death rates are rising. “While…

Read More

Eid al-Fitr and Cancer: How to Keep Foods Safe When Ramadan Ends

Janice López-Muñoz, BS, MSIH, is a public affairs specialist with the Food Safety and Inspection Service at the U.S. Department of Agriculture. More than 1 billion Muslims around the world observe Ramadan. This holy month is a time of fasting and prayer for the followers of Islam, who abstain from food and drink each day from dawn until dusk. The end of Ramadan is marked with a celebration known as Eid al-Fitr. The celebration involves large dinners, which include delicacies and large dishes of lamb, chicken, omelets, and salads. During…

Read More

Balanced Diet May Be Key to Cancer Survival

TUESDAY, June 12, 2018 (HealthDay News) — Eating a nutritionally balanced high-quality diet may lower a cancer patient’s risk of dying by as much as 65 percent, new research suggests. The finding that total diet, rather than specific nutritional components, can affect a cancer patient’s prognosis “was particularly surprising to us,” said the study’s lead author, Ashish Deshmukh. Total diet, he explained, was one that appeared to be “balanced” and “nutrient-rich” with a wide variety of vegetables, fruits, whole grains, proteins and dairy. Deshmukh is an assistant professor with the…

Read More

ASCO Annual Meeting 2018: Treatment Changes for Pancreatic Cancer and Colorectal Cancer

The theme of the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting is Delivering Discoveries: Expanding the Reach of Precision Medicine. Precision medicine has led to many advances in cancer care, but there is still much to learn in this growing field of research. Even more, as ASCO President Bruce E. Johnson, MD, FASCO, writes in this year’s Clinical Cancer Advances report, the promise of precision medicine “is only as good as our ability to make these treatments available to all patients.” While much of the cancer research at…

Read More

Colonoscopies, Endoscopies Carry Greater Infection Risk Than Thought: Study

WEDNESDAY, June 6, 2018 (HealthDay News) — Getting a colonoscopy or an endoscopy may be riskier than you thought. Researchers report that the rate of infections following these procedures at outpatient ambulatory surgery centers could be 100 times higher than previously believed, a new study finds. Bacterial infections such as E. coli and Klebsiella can strike 1 in 1,000 patients after a screening colonoscopy, nearly 2 in 1,000 after a non-screening colonoscopy, and more than 3 in 1,000 after an endoscopy, the study authors said. Previously, it had been believed…

Read More

How Advocacy Helps Me Fight Fear of My Spouse’s Recurrence

Voices on Cancer is an award-winning Cancer.Net Blog series where advocates share their stories and the lessons they have learned about being a cancer advocate. Annie Achee is the President and Medical Research Liaison of the National LeioMyoSarcoma Foundation, which builds leiomyosarcoma (LMS) awareness, provides patient and family resources, and funds research projects to accelerate treatment advances. Her advocacy work celebrates her husband, who was successfully treated for the disease. My advocacy story My husband, Mitch, a physician, was diagnosed in 2011 with leiomyosarcoma (LMS), a rare cancer I could hardly…

Read More

New Treatments May Extend Pancreatic Cancer Survival

MONDAY, June 4, 2018 (HealthDay News) — Innovative ways of using chemotherapy can significantly extend the lives of patients with pancreatic cancer, one of the most deadly cancers known, two new clinical trials report. A four-drug chemo “cocktail” extended surgical patients’ lives by nearly two years over the current standard single-drug chemo regimen for pancreatic cancer, a clinical trial out of France has shown. “You take overall survival from just under three years to almost five years,” said Dr. Daniel Labow, a cancer surgeon at Mount Sinai Hospital in New…

Read More

Reunión Anual de ASCO 2018: Necesidad de menos tratamiento para algunos pacientes con cáncer de mama y cáncer de riñón, inmunoterapia para el cáncer de pulmón de células no pequeñas y quimioterapia de mantenimiento para el rabdomiosarcoma

El tema de la Reunión Anual de la American Society of Clinical Oncology (ASCO, por sus siglas en inglés) 2018 es Aplicar los descubrimientos: Expandir el alcance de la medicina de precisión. La medicina de precisión ha permitido lograr muchos avances en la atención del cáncer, pero aún queda mucho por aprender en esta creciente área de investigación. Más aun, como el presidente de ASCO, Bruce E. Johnson, MD, FASCO, escribe en el informe sobre los avances clínicos en oncología (en inglés) de este año, la promesa de la medicina de…

Read More

Many Breast Cancer Survivors Not Getting Needed Mammograms

THURSDAY, May 31, 2018 (HealthDay News) — After surviving a diagnosis of breast cancer, women still need regular screening. But many of them, especially black women, aren’t getting the mammograms they need, a new study finds. It’s essential to screen for a return of cancer so it can be treated before symptoms appear, the researchers explained. “The use of regular mammograms to detect a return of breast cancer before any symptoms appear is associated with better overall survival,” said lead researcher Dr. Kathryn Ruddy, director of cancer survivorship at the…

Read More

Changing the Lives of People With Cancer Through Research

Whenever you hear about a new, approved treatment for cancer, that advance has been discovered, tested, and tested again through research in a clinical trial. Clinical trials are what drive progress in the way doctors and other oncology professionals understand and treat cancer. The results from these clinical trials are usually published in scientific journals, but they are also presented at scientific meetings, like the ASCO Annual Meeting. In this video, ASCO President Bruce E. Johnson, MD, FASCO, describes a presentation he saw about 10 years ago at the ASCO Annual…

Read More